MiR-455-5p Suppresses the Progression of Prostate Cancer by Targeting CCR5

Figure 1

MiR-455-5p expression and effect on the diagnosis and prognosis of patients with PCa. (a) MiR-455-5p expression levels in patients of the GSE20132 database. (b) ROC curve analysis using expression levels of miR-455-5p in PCa and normal prostate tissues. (c) Reanalyzed data from GSE20132 showed that miR-455-5p expression level increased as the Gleason score ascended. (d) Kaplan–Meier curves of the RFS of patients with PCa stratified by the tissues of miR-455-5p levels. (e) Relative miR-455-5p expression in normal prostate cells RPWE1 and PCa cells LNCAP, PC3, and DU145. , P < 0.05; , P < 0.01; , P < 0.001.

(a)

(b)

(c)

(d)

(e)

(f)